Oct 2026
Combination of Empagliflozin and Resveratrol Mitigates Hepatic Steatosis via Attenuation of Inflammation and Promotion of Adipose Tissue Browning in High‐Fat Diet‐Fed C57BL/6J Mice
The combined effects of empagliflozin and resveratrol treatment on obesity‐associated MASLD in a high‐fat diet (HFD)‐fed mouse model reduced body weight gain and improved glucose tolerance more effectively than monotherapies.
A. Soleimani, Masoume Aliabadi, Jamal Amri et al.
· The FASEB Journal · 0 citations